Junjiang Fu

48PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Flight dynamicsCancer cell biologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Apr 06, 2026
Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer.

Xia Jiang, Meiling Zheng, Lianmei Zhang

|Oct 13, 2025
Molecular biology research progress in post-mortem interval (PMI) estimation in forensic medicine.

Ting He, Binghui Song, Junjiang Fu

|Jul 23, 2025
Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo.

Jiayue He, Hui Zou, Chunli Wei

|Feb 26, 2025
TQFL19, a Novel Derivative of Thymoquinone (TQ), Plays an Essential Role by Inhibiting Cell Growth, Metastasis, and Invasion in Triple-Negative Breast Cancer.

Ali El-Far, Xiaoyan Liu, Ting Xiao

|Feb 13, 2025
Exploring the Post Mortem Interval (PMI) Estimation Model by circRNA circRnf169 in Mouse Liver Tissue.

Jiewen Fu, Binghui Song, Jie Qian

|Mar 28, 2024
The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family.

Kemeng Liu, Jiewen Fu, Kan Guo

Pageof 8

Frequent Collaborators

9 joint publications

Jingliang Cheng

6 joint publications

Jiewen Fu

5 joint publications

Md Asaduzzaman Khan

3 joint publications

Xiaotao Li